EXAMINING THE ROLE OF LEPTIN SIGNALING IN A PATIENT-DERIVED MODEL OF TRIPLE NEGATIVE BREAST CANCER

被引：0
|
作者：
Brock, C. [1 ]
Wright, M. [1 ]
Nguyen, K. [1 ]
Cheng, T. [1 ]
Collins-Burow, B. [1 ]
Bunnell, B. [2 ]
Burow, M. [1 ]
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA USA
[2] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2022年 / 70卷 / 02期
关键词：
D O I：
10.1136/jim-2022-SRMC.452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
448
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [21] Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer
    Echeverria, Gloria, V
    Cai, Shirong
    Tu, Yizheng
    Shao, Jiansu
    Powell, Emily
    Redwood, Abena B.
    Jiang, Yan
    McCoy, Aaron
    Rinkenbaugh, Amanda L.
    Lau, Rosanna
    Trevarton, Alexander J.
    Fu, Chunxiao
    Gould, Rebekah
    Ravenberg, Elizabeth E.
    Huo, Lei
    Candelaria, Rosalind
    Santiago, Lumarie
    Adrada, Beatriz E.
    Lane, Deanna L.
    Rauch, Gaiane M.
    Yang, Wei T.
    White, Jason B.
    Chang, Jeffrey T.
    Moulder, Stacy L.
    Symmans, W. Fraser
    Hilsenbeck, Susan G.
    Piwnica-Worms, Helen
    NPJ BREAST CANCER, 2023, 9 (01)
  • [22] Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling
    Cromwell, Evan F.
    Sirenko, Oksana
    Nikolov, Ekaterina
    Hammer, Matthew
    Brock, Courtney K.
    Matossian, Margarite D.
    Alzoubi, Madlin S.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    SLAS DISCOVERY, 2022, 27 (03) : 191 - 200
  • [23] Characterizing and targeting chemoresistant subclones in patient-derived xenograft models of triple negative breast cancer
    Echeverria, Gloria V.
    Seth, Sahil
    Ge, Zhongqi
    Sun, Yuting
    DiFrancesco, Emilia
    Lau, Rosanna
    Marszalek, Joe
    Moulder, Stacy
    Symmans, Fraser
    Heffernan, Timothy P.
    Chang, Jeffrey T.
    Piwnica-Worms, Helen
    CANCER RESEARCH, 2018, 78 (04)
  • [24] Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
    Miguel Martin
    Rocio Ramos-Medina
    Rebeca Bernat
    Jose Angel García-Saenz
    Maria del Monte-Millan
    Enrique Alvarez
    Maria Cebollero
    Fernando Moreno
    Eva Gonzalez-Haba
    Oscar Bueno
    Paula Romero
    Tatiana Massarrah
    Isabel Echavarria
    Yolanda Jerez
    Blanca Herrero
    Ricardo Gonzalez del Val
    Nerea Lobato
    Patricia Rincon
    Maria Isabel Palomero
    Ivan Marquez-Rodas
    Santiago Lizarraga
    Fernando Asensio
    Sara Lopez-Tarruella
    Scientific Reports, 11
  • [25] Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer
    Gloria V. Echeverria
    Shirong Cai
    Yizheng Tu
    Jiansu Shao
    Emily Powell
    Abena B. Redwood
    Yan Jiang
    Aaron McCoy
    Amanda L. Rinkenbaugh
    Rosanna Lau
    Alexander J. Trevarton
    Chunxiao Fu
    Rebekah Gould
    Elizabeth E. Ravenberg
    Lei Huo
    Rosalind Candelaria
    Lumarie Santiago
    Beatriz E. Adrada
    Deanna L. Lane
    Gaiane M. Rauch
    Wei T. Yang
    Jason B. White
    Jeffrey T. Chang
    Stacy L. Moulder
    W. Fraser Symmans
    Susan G. Hilsenbeck
    Helen Piwnica-Worms
    npj Breast Cancer, 9
  • [26] Targeting ATR to overcome Carboplatin resistance in triple-negative breast cancer patient-derived models
    Guay, Juliet
    Chabot, Catherine
    Darini, Cedric
    Buchanan, Marguerite
    Aguilar-Mahecha, Adriana
    Kong, Tim
    Yang, Connie
    Basik, Mark
    Huang, Sidong
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [27] Investigating genomic and phenotypic evolution of triple negative breast cancer chemoresistance and metastasis in patient-derived xenografts
    Echeverria, Gloria V.
    Xu, Mingchu
    Shao, Jiansu
    Zhang, Xiaomei
    Jeter-Jones, Sabrina
    Zhou, Xinhui
    Moulder, Stacy L.
    Marszalek, Joseph R.
    Heffernan, Timothy P.
    Symmans, Fraser W.
    Chang, Jeffrey T.
    Piwnica-Worms, Helen
    CANCER RESEARCH, 2020, 80 (04)
  • [28] Proteogenomic analysis of differential chemotherapy responses in patient-derived xenografts of triple-negative breast cancer
    Lei, Jonathan T.
    Huang, Chen
    Srinivasan, Ramakrishnan R.
    Vasaikar, Suhas
    Dobrolecki, Lacey E.
    Lewis, Alaina N.
    Sallas, Christina
    Hilsenbeck, Susan G.
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    Ellis, Matthew J.
    Petrosyan, Varduhi
    Saltzman, Alexander B.
    Malovannaya, Anna
    Wulf, Gerburg
    Kraushaar, Daniel C.
    Wang, Tao
    Chen, Xi
    Echeverria, Gloria V.
    Anurag, Meenakshi
    Zhang, Bing
    Lewis, Michael T.
    CANCER RESEARCH, 2022, 82 (04)
  • [29] Treatment naive patient-derived xenograft model compared to the post-neoadjuvant model from the same patient diagnosed with triple negative breast cancer
    Windsor, Gabrielle Olivia
    Matossian, Margarite
    Wright, Maryl
    Elliott, Steven
    Nguyen, Khoa
    Collins-Burow, Bridgette
    Burow, Matthew
    CANCER RESEARCH, 2021, 81 (04)
  • [30] Patient-derived xenografts in humanized mice classify metastatic potential of primary triple negative breast cancer
    Yu, Chun I.
    Wu, Te-Chia
    Kim, Kyung In
    Menghi, Francesca
    Oliveira, Vanessa
    Marches, Florentina
    Liu, Edison T.
    Banchereau, Jacques
    Palucka, Karolina
    CANCER RESEARCH, 2020, 80 (04)
12345